COVID-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says

Name: COVID-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says
Uploaded: 2021-09-20T21:20:32+00:00
Duration: 3 min 15 s
Description: Pfizer has announced positive results regarding its COVID-19 trial for children aged 5 to 11. The biopharmaceutical company says its data shows its vaccine is not only safe but very protective.

WXYZ Published September 20, 2021 31 Views

Rumble — Pfizer has announced positive results regarding its COVID-19 trial for children aged 5 to 11. The biopharmaceutical company says its data shows its vaccine is not only safe but very protective.